Inflammasome-mediated corneal epithelial cell defenses inhibited by pathogenic bacteria

致病菌抑制炎症小体介导的角膜上皮细胞防御

基本信息

  • 批准号:
    10688090
  • 负责人:
  • 金额:
    $ 37.73万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-01 至 2027-04-30
  • 项目状态:
    未结题

项目摘要

Project Summary/Abstract The healthy corneal epithelium is an effective barrier to pathogenic and environmental bacteria. Because of this, corneal infection or keratitis models often rely on bypassing the epithelium altogether by introducing microbes directly into the corneal stroma, where they initiate immune cell responses that can damage tissue and cause vision-threatening scarring. A limitation of this experimental approach is that epithelial defense mechanisms are unable to be identified or investigated. The bacterial pathogen Pseudomonas aeruginosa is the most common infection associated with soft contact lens wear, suggesting it is uniquely capable of causing infection in the stroma even when the epithelium remains intact. One way in which P. aeruginosa colonizes the epithelium is by invading and replicating inside epithelial cells, which has been investigated in cultured cells, and observed in mouse corneal infection models. Preliminary data show that the toxin ExoS produced by P. aeruginosa suppresses caspase-4 mediated pyroptosis of invaded corneal epithelial cells, buying time for bacteria to replicate in a protected niche. Additional data indicate that a different inflammasome pathway is also active in corneal epithelial cells, and leads to production of the cytokine IL-1β, which ExoS also suppresses. Therefore, a novel role for ExoS in corneal infection could be to prolong a niche for bacteria to replicate within corneal epithelial cells, while limiting secretion of cytokines that recruit immune cells. Using imaging methods to selectively monitor invaded cells, and CRISPR-Cas9 to manipulate corneal epithelial cells genetically, we will answer three outstanding questions regarding both corneal epithelial defense, and bacterial subversion of it: 1. How does ExoS block caspase-4-mediated pyroptosis? 2. How do corneal epithelial cells detect and respond to P. aeruginosa? 3. What is the significance of epithelial cell inflammasome activation and pyroptosis in protecting the eye from developing keratitis in the stroma? Successful completion of these aims will identify a new mechanism of host defense at the ocular surface, further our understanding of inflammasomes in epithelial cells, and elucidate how a uniquely devastating corneal pathogen is able to overcome host defenses.
项目总结/摘要 健康的角膜上皮是病原菌和环境细菌的有效屏障。因为 因此,角膜感染或角膜炎模型通常依赖于通过引入 微生物直接进入角膜基质,在那里它们启动可能损害组织的免疫细胞反应 造成威胁视力的疤痕这种实验方法的局限性在于上皮防御 机制无法确定或调查。细菌病原体绿脓杆菌是 最常见的感染与软性接触透镜配戴有关,这表明它是唯一能够引起 即使在上皮保持完整的情况下,基质中也存在感染。铜绿假单胞菌定植于 上皮是通过侵入上皮细胞并在上皮细胞内复制,这已经在培养的细胞中进行了研究, 并在小鼠角膜感染模型中观察到。初步数据显示,由P. 铜绿假单胞菌抑制半胱天冬酶-4介导的侵入角膜上皮细胞的焦亡, 细菌在受保护的生态位中复制。另外的数据表明,不同的炎性小体途径, 在角膜上皮细胞中也有活性,并导致细胞因子IL-1β的产生,ExoS也 抑制。因此,ExoS在角膜感染中的新作用可能是延长细菌的生态位, 在角膜上皮细胞内复制,同时限制招募免疫细胞的细胞因子的分泌。使用 选择性监测侵入细胞的成像方法,以及CRISPR-Cas9操纵角膜上皮细胞 从遗传学上讲,我们将回答三个悬而未决的问题,既关于角膜上皮防御, 颠覆它:1. ExoS如何阻断caspase-4介导的细胞凋亡?2.角膜上皮细胞是如何 检测并应对铜绿假单胞菌?3.上皮细胞炎性小体激活和 角膜炎在保护眼睛免受基质角膜炎的发展方面有何作用?圆满完成这些目标 将确定一个新的机制,宿主防御在眼表,进一步了解 上皮细胞中的炎性小体,并阐明了一种独特的破坏性角膜病原体是如何能够 克服宿主的防御

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Abby R Kroken其他文献

Abby R Kroken的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Abby R Kroken', 18)}}的其他基金

Inflammasome-mediated corneal epithelial cell defenses inhibited by pathogenic bacteria
致病菌抑制炎症小体介导的角膜上皮细胞防御
  • 批准号:
    10502998
  • 财政年份:
    2022
  • 资助金额:
    $ 37.73万
  • 项目类别:
Corneal infection: bacterial localization versus virulence
角膜感染:细菌定位与毒力
  • 批准号:
    8983859
  • 财政年份:
    2015
  • 资助金额:
    $ 37.73万
  • 项目类别:
Corneal infection: bacterial localization versus virulence
角膜感染:细菌定位与毒力
  • 批准号:
    9313891
  • 财政年份:
    2015
  • 资助金额:
    $ 37.73万
  • 项目类别:
Corneal infection: bacterial localization versus virulence
角膜感染:细菌定位与毒力
  • 批准号:
    9169926
  • 财政年份:
    2015
  • 资助金额:
    $ 37.73万
  • 项目类别:

相似海外基金

Control of genomic integrity and virulence of Aspergillus fumigatus by ADP-ribosylation.
通过 ADP-核糖基化控制烟曲霉的基因组完整性和毒力。
  • 批准号:
    MR/X007472/1
  • 财政年份:
    2023
  • 资助金额:
    $ 37.73万
  • 项目类别:
    Fellowship
Understanding the impact of DNA ADP-ribosylation on telomere function in cancer cells
了解 DNA ADP-核糖基化对癌细胞端粒功能的影响
  • 批准号:
    10751121
  • 财政年份:
    2023
  • 资助金额:
    $ 37.73万
  • 项目类别:
Composition and function of telomeric multi-protein complexes and their regulation by ADP-ribosylation
端粒多蛋白复合物的组成和功能及其ADP-核糖基化的调节
  • 批准号:
    2748032
  • 财政年份:
    2022
  • 资助金额:
    $ 37.73万
  • 项目类别:
    Studentship
A Chemical Footprinting Approach towards Poly-ADP-Ribosylation-regulated Biomolecular Condensation
聚 ADP 核糖基化调节生物分子缩合的化学足迹方法
  • 批准号:
    10524783
  • 财政年份:
    2022
  • 资助金额:
    $ 37.73万
  • 项目类别:
Regulation of DNA repair by histone ADP-ribosylation
组蛋白 ADP 核糖基化调节 DNA 修复
  • 批准号:
    MR/W017350/1
  • 财政年份:
    2022
  • 资助金额:
    $ 37.73万
  • 项目类别:
    Research Grant
Regulation and function of site-specific protein poly-ADP-ribosylation
位点特异性蛋白质聚 ADP 核糖基化的调控和功能
  • 批准号:
    10668492
  • 财政年份:
    2022
  • 资助金额:
    $ 37.73万
  • 项目类别:
ADP-ribosylation of DNA in Mycobacterium tuberculosis
结核分枝杆菌 DNA 的 ADP-核糖基化
  • 批准号:
    BB/W016613/1
  • 财政年份:
    2022
  • 资助金额:
    $ 37.73万
  • 项目类别:
    Research Grant
A Chemical Footprinting Approach towards Poly-ADP-Ribosylation-regulated Biomolecular Condensation
聚 ADP 核糖基化调节生物分子缩合的化学足迹方法
  • 批准号:
    10610165
  • 财政年份:
    2022
  • 资助金额:
    $ 37.73万
  • 项目类别:
Role of Transcription Factor ADP-ribosylation in Breast Cancer Biology
转录因子 ADP-核糖基化在乳腺癌生物学中的作用
  • 批准号:
    10593900
  • 财政年份:
    2021
  • 资助金额:
    $ 37.73万
  • 项目类别:
A Chemical Footprinting Approach towards Poly-ADP-Ribosylation-regulated Biomolecular Condensation
聚 ADP 核糖基化调节生物分子缩合的化学足迹方法
  • 批准号:
    10389853
  • 财政年份:
    2021
  • 资助金额:
    $ 37.73万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了